Repository of National Pirogov Memorial Medical University, Vinnytsia

The effect of the reparative action drug in treatment of pediatric duodenal ulcer

Show simple item record

dc.contributor.author Dudnyk, V. M. en
dc.contributor.author Buhlova, N. O. en
dc.contributor.author Morozova, I. V. en
dc.contributor.author Kukuruza, T. Y. en
dc.date.accessioned 2023-11-06T09:05:00Z en
dc.date.available 2023-11-06T09:05:00Z en
dc.date.issued 2022
dc.identifier DOI: 10.15574/PP.2022.92.33 en
dc.identifier.citation The effect of the reparative action drug in treatment of pediatric duodenal ulcer / V. M. Dudnyk, N.O. Buhlova, I.V. Morozova, T.Y. Kukuruza // Ukrainian journal Perinatology and Pediatrics. – 2022. – 4 (92). – P. 33–36. en
dc.identifier.uri https://dspace.vnmu.edu.ua/123456789/6352 en
dc.description.abstract Digestive tract diseases occupy one of the first places in the structure of childhood pathology, including duodenal ulcers (DU), the development of which in 70–100% of cases is associated with H.pylori infection. It is found that the important role in the development of inflammatory process in digestive tract have toll-like receptors 4 (TLR4), due to reactiveness to H.pylori. It is proved that growth factors, in particular epidermal growth factor (EGF), are able to influence on the healing processes in the mucous membrane. It is advisable to include drugs of reparative action in complex treatment of pediatric DU. en
dc.language.iso en en
dc.subject children en
dc.subject duodenal ulcer en
dc.subject drug of reparative function en
dc.subject H.pylori en
dc.title The effect of the reparative action drug in treatment of pediatric duodenal ulcer en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics